Health
Study shows Oxford Covid vaccine has less protection against South African variant – The Guardian
Researchers say vaccines’ focus must shift to protecting people from hospitalisation and death
The Oxford/AstraZeneca vaccine will not stop people becoming ill if they contract the South African variant of Covid-19, researchers have confirmed, warning that vaccines focus needs to shift from population immunity to protecting individuals from hospitalisation and death.
The small study in 2,000 people aged 31, who are less likely to become severely ill, adds to evidence from big trials of other vaccines carried out after the variant appeared in South Africa. Trial data from the Janssen and Novavax…
-
Business23 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Business23 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News23 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Noosa News23 hours agoDid AI write your accounting expert’s report? – Proctor